References
- Ahn GO, Seita J, Hong BJ, et al (2014). Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci U S A, 111, 2698-703. https://doi.org/10.1073/pnas.1320243111
- Ayala A, Munoz MF, Arguelles S (2014). Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev, 2014, 360438.
- Bennaars-Eiden A, Higgins L, Hertzel AV, et al (2002). Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J Biol Chem, 277, 50693-702. https://doi.org/10.1074/jbc.M209493200
- Caito S, Rajendrasozhan S, Cook S, et al (2010). SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J, 24, 3145-59. https://doi.org/10.1096/fj.09-151308
- Cao ZG, Xu X, Xue YM,Zhao SL (2014). Comparison of 4-hydroxynonenal-induced p53-mediated apoptosis in prostate cancer cells LNCaP and DU145. Contemp Oncol (Pozn), 18, 22-8.
- Chen Y, Fu LL, Wen X, et al (2014). Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis, 5, 1047. https://doi.org/10.1038/cddis.2014.14
- Christov PP, Hawkins EK, Kett NR, et al (2013). Simplified synthesis of individual stereoisomers of the 4-hydroxynonenal adducts of deoxyguanosine. Tetrahedron Lett, 54, 4289-91. https://doi.org/10.1016/j.tetlet.2013.06.004
- Dalleau S, Baradat M, Gueraud F, et al (2013). Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ, 20, 1615-30. https://doi.org/10.1038/cdd.2013.138
- Finley LW, Carracedo A, Lee J, et al (2011). SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell, 19, 416-28. https://doi.org/10.1016/j.ccr.2011.02.014
- Fritz KS, Galligan JJ, Smathers RL, et al (2011). 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem Res Toxicol, 24, 651-62. https://doi.org/10.1021/tx100355a
- Groulx I, Lee S (2002). Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclearcytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol, 22, 5319-36. https://doi.org/10.1128/MCB.22.15.5319-5336.2002
- Jin H, Zangar RC (2009). Protein modifications as potential biomarkers in breast cancer. Biomark Insights, 4, 191-200.
- Ke Q, Costa M (2006). Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol, 70, 1469-80. https://doi.org/10.1124/mol.106.027029
- Kim JW, Tchernyshyov I, Semenza GL, et al (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab, 3, 177-85. https://doi.org/10.1016/j.cmet.2006.02.002
- Lee S, Chen TT, Barber CL, et al (2007). Autocrine VEGF signaling is required for vascular homeostasis. Cell, 130, 691-703. https://doi.org/10.1016/j.cell.2007.06.054
- Li DW, Dong P, Wang F, et al (2013). Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1 alpha. Asian Pac J Cancer Prev, 14, 4853-8. https://doi.org/10.7314/APJCP.2013.14.8.4853
- Lopez-Lazaro M (2006). HIF-1: hypoxia-inducible factor or dysoxia-inducible factor? FASEB J, 20, 828-32. https://doi.org/10.1096/fj.05-5168hyp
- Macpherson LJ, Xiao B, Kwan KY, et al (2007). An ion channel essential for sensing chemical damage. J Neurosci, 27, 11412-5. https://doi.org/10.1523/JNEUROSCI.3600-07.2007
- Maxwell PH, Wiesener MS, Chang GW, et al (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-5. https://doi.org/10.1038/20459
- Park JH, Kim TY, Jong HS, et al (2003). Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin Cancer Res, 9, 433-40.
- Patrick B, Li J, Jeyabal PV, et al (2005). Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression. Biochem Biophys Res Commun, 334, 425-32. https://doi.org/10.1016/j.bbrc.2005.06.099
- Pugh CW, Ratcliffe PJ (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med, 9, 677-84. https://doi.org/10.1038/nm0603-677
- Ryan BJ, Nissim A, Winyard PG (2014). Oxidative posttranslational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biol, 2, 715-24. https://doi.org/10.1016/j.redox.2014.05.004
- Sharma R, Sharma A, Dwivedi S, et al (2008). 4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. Biochemistry, 47, 143-56. https://doi.org/10.1021/bi701559f
- Sharma R, Sharma A, Chaudhary P, et al (2012). Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane. Free Radic Biol Med, 52, 2177-85. https://doi.org/10.1016/j.freeradbiomed.2012.04.012
- Shearn CT, Fritz KS, Reigan P, et al (2011a). Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells. Biochemistry, 50, 3984-96. https://doi.org/10.1021/bi200029w
- Shearn CT, Smathers RL, Stewart BJ, et al (2011b). Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition by 4-hydroxynonenal leads to increased Akt activation in hepatocytes. Mol Pharmacol, 79, 941-52. https://doi.org/10.1124/mol.110.069534
- Sovic A, Borovic S, Loncaric I, et al (2001). The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res, 21, 1997-2004.
- Stroka DM, Burkhardt T, Desbaillets I, et al (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J, 15, 2445-53.
- Szakacs G, Paterson JK, Ludwig JA, et al (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov, 5, 219-34. https://doi.org/10.1038/nrd1984
- Ulrich HD (2007). SUMO teams up with ubiquitin to manage hypoxia. Cell, 131, 446-7. https://doi.org/10.1016/j.cell.2007.10.026
- Usatyuk PV, Natarajan V (2012). Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvasc Res, 83, 45-55. https://doi.org/10.1016/j.mvr.2011.04.012
- van Hagen M, Overmeer RM, Abolvardi SS, et al (2010). RNF4 and VHL regulate the proteasomal degradation of SUMOconjugated Hypoxia-Inducible Factor-2alpha. Nucleic Acids Res, 38, 1922-31. https://doi.org/10.1093/nar/gkp1157
- Vatsyayan R, Lelsani PC, Chaudhary P, et al (2012). The expression and function of vascular endothelial growth factor in retinal pigment epithelial (RPE) cells is regulated by 4-hydroxynonenal (HNE) and glutathione S-transferaseA4-4. Biochem Biophys Res Commun, 417, 346-51. https://doi.org/10.1016/j.bbrc.2011.11.113
- Xu N, Lei Z, Li XL, et al (2013). Clinical study of tumor angiogenesis and perfusion imaging using multi-slice spiral computed tomography for breast cancer. Asian Pac J Cancer Prev, 14, 429-33. https://doi.org/10.7314/APJCP.2013.14.1.429
- Zhu K, Jiao H, Li S, et al (2013). ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment. J Bone Miner Res, 28, 1870-8 https://doi.org/10.1002/jbmr.1958
Cited by
- Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products vol.5, pp.1, 2016, https://doi.org/10.3390/antiox5010007
- Voltage-gated calcium channels: Novel targets for cancer therapy vol.14, pp.2, 2017, https://doi.org/10.3892/ol.2017.6457